Intramural hematoma and penetrating aortic ulcer

Current Opinion in Cardiology

Volumn 22, Issue 6, 2007, Pages 504-509

  Sundt, Thoralf M ^a  

^a MAYO CLINIC   (United States)

Author keywords

Acute aortic dissection; Acute aortic syndrome; Endovascular stent grafting; Intramural hematoma; Penetrating aortic ulcer

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

AORTA VALVE DISEASE; HEMATOMA; HUMAN; MORBIDITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REVIEW; SURGICAL RISK; TECHNOLOGY;

AORTIC DISEASES; HEMATOMA; HUMANS; STENTS; ULCER; VASCULAR SURGICAL PROCEDURES;

EID: 35148863114     PISSN: 02684705     EISSN: None     Source Type: Journal    
DOI: 10.1097/HCO.0b013e3282f0fd72     Document Type: Review

References (49)

1. Vilacosta I, Roman JA. Acute aortic syndrome. Heart 2001; 85:365-368.
2. Hansen MS, Nogareda GJ, Hutchison SJ. Frequency of and inappropriate treatment of misdiagnosis of acute aortic dissection. Am J Cardiol 2007; 99:852-856. This intriguing study reviewed the course of patients admitted to a tertiary care center who were ultimately found to have AAS. In almost 40% of cases the diagnosis was missed, being most often confused with ACS. Furthermore, associated with this error, and resultant exposure of these patients to antithrombotic agents, was an increased incidence of hemorrhagic complications. Attention to the problem of misdiagnosis and efforts to reduce it may have an important impact on the outcome of patients suffering from these conditions.
3. Mohr-Kahaly S. Aortic intramural hematoma: from observation to therapeutic strategies. J Am Coll Cardiol 2001; 37:1611-1613.
4. Svensson LG, Labib SB, Eisenhauer AC, Butterly JR. Intimal tear without hematoma: an important variant of aortic dissection that can elude current imaging techniques. Circulation 1999; 99:1331-1336.
5. Stanson AW, Kazmier FJ, Hollier LH, et al. Penetrating atherosclerotic ulcers of the thoracic aorta: natural history and clinicopathologic correlations. Ann Vasc Surg 1986; 1:15-23.
6. Hussain S, Glover JL, Bree R, Bendick PJ. Penetrating atherosclerotic ulcers of the thoracic aorta. J Vasc Surg 1989; 9:710-717.
7. Kazerooni EA, Bree RL, Williams DM. Penetrating atherosclerotic ulcers of the descending thoracic aorta: evaluation with CT and distinction from aortic dissection. Radiology 1992; 183:759-765.
8. Tittle SL, Lynch RJ, Cole PE, et al. Midterm follow-up of penetrating ulcer and intramural hematoma of the aorta. J Thorac Cardiovasc Surg 2002; 123:1051-1059.
9. Cho KR, Stanson AW, Potter DD, et al. Penetrating atherosclerotic ulcer of the descending thoracic aorta and arch. J Thorac Cardiovasc Surg 2004; 127:1393-1399.
10. Attia C, Villard J, Boussel L, et al. Endovascular repair of localized pathological lesions of the descending thoracic aorta: midterm results. Cardiovasc Intervent Radiol 2007; 17 May [Epub ahead of print]. This report substantiates the application of stent-graft technology to a variety of thoracic aortic lesions including PAU (three cases) in elective and emergent (15 or 40) cases. While primary technical success was achieved in 92.5% of cases, the 30-day mortality rate was 10%.
11. Stone DH, Brewster DC, Kwolek CJ, et al. Stent-graft versus open-surgical repair of the thoracic aorta: mid-term results. J Vasc Surg 2006; 44:1188-1197. These authors compare their own stent-graft and contemporaneous open surgical results in the treatment of thoracic aortic conditions. Perioperative mortality was lower (albeit not statistically significantly so) for the endovascular group, but survival at 48 months higher for the surgical group. There was no apparent difference in spinal cord complications or re-interventions.
12. Chiesa R, Melissano G, Marrocco-Trischitta MM, et al. Spinal cord ischemia after elective stent-graft repair of the thoracic aorta. J Vasc Surg 2005; 42:11-17.
13. Demers P, Miller DC, Mitchell RS, et al. Stent-graft repair of penetrating atherosclerotic ulcers in the descending thoracic aorta: mid-term results. Ann Thorac Surg 2004; 77:81-86.
14. Piffaretti G, Tozzi M, Lomazzi C, et al. Penetrating ulcers of the thoracic aorta: results from a single-centre experience. Am J Surg 2007; 193:443-447. In this series of 11 patients with 12 PAUs, endovascular stent-grafts were successfully deployed in all, with no hospital mortality and no instances of paraplegia. This demonstrates that, with appropriate patient selection and surgical expertise, this technology can be applied safely to treat PAU.
15. Brinster DR, Wheatley GH 3rd, Williams J, et al. Are penetrating aortic ulcers best treated using an endovascular approach? Ann Thorac Surg 2006; 82:1688-1691. Another series, this time of 21 patients, with PAU treated endovascularly, showed a 30-day mortality rate of 0%, arguing safety in treating PAU with endografts. Unfortunately, given the data, the question posed by the authors cannot really be answered, as there is no surgical control group (although one would expect the risks to be far higher) and, more importantly, no medical control group. In the management of PAU, the question will ultimately likely be stent graft or pharmacotherapy. One's view on this will be colored by one's view of the data concerning the natural history of the disease: the Yale view of a malignant course will encourage repair of most, if not all, PAU, while the Mayo study suggests a more expectant approach may be adopted.
16. Eggebrecht H, Herold U, Schmermund A, et al. Endovascular stent-graft treatment of penetrating aortic ulcer: results over a median follow-up of 27 months. Am Heart J 2006; 151:530-536. Follow-up out to 62 months (median 27 months) of 22 patients with PAU demonstrates good durability of the repair, with only one patient requiring reintervention (for type 1 endoleak) and survival of 100% at 1 year and 82.5% at 2 years.
17. Estrera AL, Miller CC 3rd, Chen EP, et al. Descending thoracic aortic aneurysm repair: 12-year experience using distal aortic perfusion and cerebrospinal fluid drainage. Ann Thorac Surg 2005; 80:1290-1296.
18. Krukenberg E. Contribution to the question of dissecting aneurysm [in German]. Beitr Pathol Anat Allg Pathol 1920; 67:329-351.
19. Evangelista A, Mukherjee D, Mehta RH, et al. Acute intramural hematoma of the aorta. A mystery in evolution. Circulation 2005; 111:1063-1070.
20. Gore I. Pathogenesis of dissecting aneurysm of the aorta. AMA Arch Pathol 1952; 53:142-153.
21. Hirst AE Jr, Johns VJ Jr, Kime SW. Dissecting aneurysm of the aorta: a review of 505 cases. Medicine (Baltimore) 1958; 37:217-279.
22. Yamada T, Tada S, Harada J. Aortic dissection without intimal rupture: diagnosis with MR imaging and CT. Radiology 1988; 168:347-352.
23. Song JK, Kim HS, Kang DH, et al. Different clinical features of aortic intramural hematoma versus dissection involving the ascending aorta. J Am Coll Cardiol 2001; 37:1604-1610.
24. Shimizu H, Yoshino H, Udagawa H, et al. Prognosis of aortic intramural hemorrhage compared with classic aortic dissection. Am J Cardiol 2000; 85:792-795.
25. Sundt TM 3rd. Residual strain in the aorta. J Thorac Cardiovasc Surg 2006; 131:1420-1421.
26. Uchida K, Imoto K, Takahashi M, et al. Pathologic characteristics and surgical indications of superacute type A intramural hematoma. Ann Thorac Surg 2005; 79:1518-1521.
27. Ledbetter S, Stuk JL, Kaufman JA. Helical (spiral) CT in the evaluation of emergent thoracic aortic syndromes. Traumatic aortic rupture, aortic aneurysm, aortic dissection, intramural hematoma, and penetrating atherosclerotic ulcer. Radiol Clin North Am 1999; 37:575-589.
28. Hayashi H, Matsuoka Y, Sakamoto I, et al. Penetrating atherosclerotic ulcer of the aorta: imaging features and disease concept. Radiographics 2000; 20:995-1005.
29. Macura KJ, Szarf G, Fishman EK, Bluemke DA. Role of computed tomography and magnetic resonance imaging in assessment of acute aortic syndromes. Semin Ultrasound CT MR 2003; 24:232-254.
30. Mohr-Kahaly S, Erbel R, Kearney P, et al. Aortic intramural hemorrhage visualized by transesophageal echocardiography: findings and prognostic implications. J Am Coll Cardiol 1994; 23:658-664.
31. Kaji S, Nishigami K, Akasaka T, et al. Prediction of progression or regression of type A aortic intramural hematoma by computed tomography. Circulation 1999; 100 (19 Suppl):II281-II286.
32. Maraj R, Rerkpattanapipat P, Jacobs LE, et al. Meta-analysis of 143 reported cases of aortic intramural hematoma. Am J Cardiol 2000; 86: 664-668.
33. Nienaber CA, von Kodolitsch Y, Petersen B, et al. Intramural hemorrhage of the thoracic aorta. Diagnostic and therapeutic implications. Circulation 1995; 92:1465-1472.
34. Robbins RC, McManus RP, Mitchell RS, et al. Management of patients with intramural hematoma of the thoracic aorta. Circulation 1993; 88 (Suppl II):II1-II10.
35. von Kodolitsch Y, Csosz SK, Koschyk DH, et al. Intramural hematoma of the aorta: predictors of progression to dissection and rupture. Circulation 2003; 107:1158-1163.
36. Song JK, Kim HS, Song JM, et al. Outcomes of medically treated patients with aortic intramural hematoma. Am J Med 2002; 113:181-187.
37. Nishigami K, Tsuchiya T, Shono H, et al. Disappearance of aortic intramural hematoma and its significance to the prognosis. Circulation 2000; 102 (19 Suppl 3):III243-III247.
38. Kaji S, Akasaka T, Katayama M, et al. Long-term prognosis of patients with type B aortic intramural hematoma. Circulation 2003; 108:9.
39. Sueyoshi E, Imada T, Sakamoto I, et al. Analysis of predictive factors for progression of type B aortic intramural hematoma with computed tomography. Journal of Vascular Surgery 2002; 35:1179-1183.
40. Sueyoshi E, Sakamoto I, Uetani M, Matsuoka Y. CT analysis of the growth rate of aortic diameter affected by acute type B intramural hematoma. AJR Am J Roentgenol 2006; 186 (6 Suppl 2):S414-S420. This careful CT study of 54 patients with type B IMH demonstrated aortic expansion in 37% of individuals. There was actual shrinkage during the first year (mean growth -2.2 ± 5.7 mm/year), but expansion thereafter (at a rate of 0.4 ± 3.2 mm/year), demonstrating the importance of long-term follow-up as argued emphatically by Elefteriades and colleagues at Yale.
41. Coady MA, Rizzo JA, Elefteriades JA. Pathologic variants of thoracic aortic dissections. Penetrating atherosclerotic ulcers and intramural hematomas. Cardiol Clin 1999; 17:637-657.
42. Grabenwoger M, Fleck T, Czerny M, et al. Endovascular stent graft placement in patients with acute thoracic aortic syndromes. Eur J Cardiothorac Surg 2003; 23:788-793; discussion 793.
43. Dake MD, Kato N, Mitchell RS, et al. Endovascular stent-graft placement for the treatment of acute aortic dissection. N Engl J Med 1999; 340:1546-1552.
44. Kaya A, Heijmen RH, Overtoom TT, et al. Thoracic stent grafting for acute aortic pathology. Ann Thorac Surg 2006; 82:560-565. This series of 28 patients included four with IMH and one with PAU as well as 12 complicated type B dissections. Although one cannot necessarily hold the technology responsible for the hospital mortality rate of 21% given the extreme condition of many of the candidates, there were new neurologic symptoms in four patients, demonstrating that use of the technology is not without risk.
45. Ganaha F, Miller DC, Sugimoto K, et al. Prognosis of aortic intramural hematoma with and without penetrating atherosclerotic ulcer: a clinical and radiological analysis. Circulation 2002; 106:342-348.
46. Moizumi Y, Komatsu T, Motoyoshi N, Tabayashi K. Management of patients with intramural hematoma involving the ascending aorta. J Thorac Cardiovasc Surg 2002; 124:918-924.
47. Song JK, Kang SJ, Song JM, et al. Factors associated with in-hospital mortality in patients with acute aortic syndrome involving the ascending aorta. Int J Cardiol 2007; 115:14-18. This report updates the Korean experience with type A IMH and dissection. Of particular note, the overall mortality rate for type A IMH was 8%. With 31% of IMH patients ultimately undergoing surgery, the operative mortality rate was actually lower, at 6%. This weakens the argument against surgery in my view, as does the higher prevalence of tamponade observed among those with IMH than those with acute dissection (25% versus 11%). Among those with IMH and tamponade, the mortality rate among surgically treated patients was 20% as compared with 29% with paracentesis and medical management. Why then wait for the patient to develop tamponade? It does show, however, that for particularly high-operativerisk patients with low risk of progression of their IMH, there may be a (very small and specific) place for nonoperative management.
48. Kaji S, Akasaka T, Horibata Y, et al. Long-term prognosis of patients with type a aortic intramural hematoma. Circulation 2002; 106 (12 Suppl 1):I248-I252.
49. Moizumi Y, Komatsu T, Motoyoshi N, Tabayashi K. Clinical features and long-term outcome of type A and type B intramural hematoma of the aorta. J Thorac Cardiovasc Surg 2004; 127:421-427.